Clinical Trial Update: The Effectiveness of 3% Topical Tranexamic Acid Compared to 4% Topical Hydroquinone as Therapy of Melasma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 3% topical tranexamic acid to 4% topical hydroquinone for the treatment of melasma; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Hydroquinone 4% topical (hydroquinone)
• Tranexamic acid 3% topical (tranexamic acid)

Snippet

Sponsor: Indonesia University | Conditions: Melasma | Phase 3 | Status: UNKNOWN